Cardiovascular Primary Prevention - Directed Approach for Individual Features

Detalhes bibliográficos
Autor(a) principal: Mano, T
Data de Publicação: 2019
Outros Autores: Aguiar Rosa, S, Rio, P, Timóteo, AT, Cruz Ferreira, R
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3419
Resumo: Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as “one-dose-fits-all strategy” remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification.
id RCAP_587c64b0a81b5fa0e8581c33c4db8181
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/3419
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cardiovascular Primary Prevention - Directed Approach for Individual FeaturesHSM CARCardiovascular Primary PreventionCardiovascular Risk FactorsCardiovascular DiseasesLifestyle ChangesCardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as “one-dose-fits-all strategy” remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification.Sociedade Portuguesa de NefrologiaRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEMano, TAguiar Rosa, SRio, PTimóteo, ATCruz Ferreira, R2020-02-06T13:29:26Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3419engPort J Nephrol Hypert 2019; 33(2): 107-114info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:42:55Zoai:repositorio.chlc.min-saude.pt:10400.17/3419Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:43.825536Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cardiovascular Primary Prevention - Directed Approach for Individual Features
title Cardiovascular Primary Prevention - Directed Approach for Individual Features
spellingShingle Cardiovascular Primary Prevention - Directed Approach for Individual Features
Mano, T
HSM CAR
Cardiovascular Primary Prevention
Cardiovascular Risk Factors
Cardiovascular Diseases
Lifestyle Changes
title_short Cardiovascular Primary Prevention - Directed Approach for Individual Features
title_full Cardiovascular Primary Prevention - Directed Approach for Individual Features
title_fullStr Cardiovascular Primary Prevention - Directed Approach for Individual Features
title_full_unstemmed Cardiovascular Primary Prevention - Directed Approach for Individual Features
title_sort Cardiovascular Primary Prevention - Directed Approach for Individual Features
author Mano, T
author_facet Mano, T
Aguiar Rosa, S
Rio, P
Timóteo, AT
Cruz Ferreira, R
author_role author
author2 Aguiar Rosa, S
Rio, P
Timóteo, AT
Cruz Ferreira, R
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Mano, T
Aguiar Rosa, S
Rio, P
Timóteo, AT
Cruz Ferreira, R
dc.subject.por.fl_str_mv HSM CAR
Cardiovascular Primary Prevention
Cardiovascular Risk Factors
Cardiovascular Diseases
Lifestyle Changes
topic HSM CAR
Cardiovascular Primary Prevention
Cardiovascular Risk Factors
Cardiovascular Diseases
Lifestyle Changes
description Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as “one-dose-fits-all strategy” remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
2020-02-06T13:29:26Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3419
url http://hdl.handle.net/10400.17/3419
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Port J Nephrol Hypert 2019; 33(2): 107-114
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131303719731200